Patient-Reported Symptoms and Sequelae 12 Months After COVID-19 in Hospitalized Adults: A Multicenter Long-Term Follow-Up Study.

COVID-19 SARS-CoV-2 dyspnea long COVID-19 long-term sequelae

Journal

Frontiers in medicine
ISSN: 2296-858X
Titre abrégé: Front Med (Lausanne)
Pays: Switzerland
ID NLM: 101648047

Informations de publication

Date de publication:
2022
Historique:
received: 13 12 2021
accepted: 28 02 2022
entrez: 8 4 2022
pubmed: 9 4 2022
medline: 9 4 2022
Statut: epublish

Résumé

Our knowledge on the long-term consequences of COVID-19 is still scarce despite the clinical relevance of persisting syndrome. The aim of this study was to analyze patient-reported outcomes, including assessment by specific questionnaires of health impairment and symptoms. This is a prospective, observational and multicenter cohort study coordinated by Fondazione IRCSS Ca' Granda Ospedale Maggiore Policlinico di Milano and Istituto di Ricerche Farmacologiche Mario Negri IRCCS including eight hospitals located in North and Central Italy. A telephone interview to assess rehospitalization, access to health care resources, general health status subjective evaluation, and symptoms was performed at 12 months after the discharge in patients admitted to hospital because of COVID-19 from February 2020 to the end of May 2020. Among the 776 patients discharged alive, 44 (5.7%) died, 456 subjects (58.8%) completed the questionnaire and 276 (35.6%) were not reachable or refused to join the telephone interview. The mean age of the study population was 59.4 years (SD 14.1), 69.8% of individuals needed oxygen support during hospitalization and 10.4% were admitted to ICU. Overall, 91.7% of participants reported at least one symptom/sequela at 12 months. Exertional dyspnea (71.7%), fatigue (54.6%), and gastrointestinal symptoms (32.8%) were the most reported ones. Health issues after discharge including hospitalization or access to emergency room were described by 19.4% of subjects. Female and presence of comorbidities were independent predictors of whealth impairment and presence of ≥2 symptoms/sequelae after 12 months from hospitalization for COVID-19. Patient-reported symptoms and sequelae, principally dyspnea and fatigue, are found in most individuals even 12 months from COVID-19 hospitalization. Long-term follow-up based on patient-centered outcome can contribute to plan tailored interventions.

Identifiants

pubmed: 35391879
doi: 10.3389/fmed.2022.834354
pmc: PMC8981315
doi:

Types de publication

Journal Article

Langues

eng

Pagination

834354

Informations de copyright

Copyright © 2022 Comelli, Viero, Bettini, Nobili, Tettamanti, Galbussera, Muscatello, Mantero, Canetta, Martinelli Boneschi, Arighi, Brambilla, Vecchi, Lampertico, Bonfanti, Contoli, Blasi, Gori, Bandera.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Clin Microbiol Infect. 2021 Oct;27(10):1507-1513
pubmed: 34111579
Infect Dis Ther. 2021 Sep;10(3):1579-1590
pubmed: 34152573
Chest. 1988 Mar;93(3):580-6
pubmed: 3342669
Lancet. 2021 Jan 16;397(10270):220-232
pubmed: 33428867
JAMA. 2020 Aug 11;324(6):603-605
pubmed: 32644129
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Lancet Respir Med. 2021 Jul;9(7):747-754
pubmed: 33964245
J Gen Intern Med. 2021 Mar;36(3):738-745
pubmed: 33443703
ERJ Open Res. 2020 Oct 26;6(4):
pubmed: 33257910
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Arch Intern Med. 2007 Jun 25;167(12):1312-20
pubmed: 17592106
Nat Med. 2021 Apr;27(4):626-631
pubmed: 33692530
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Lancet. 2021 Jan 16;397(10270):173-175
pubmed: 33428868
Lung. 2021 Apr;199(2):113-119
pubmed: 33569660
JAMA Cardiol. 2020 Nov 1;5(11):1265-1273
pubmed: 32730619
Clin Microbiol Infect. 2022 Apr;28(4):611.e9-611.e16
pubmed: 34763058
Int Forum Allergy Rhinol. 2021 Dec;11(12):1685-1688
pubmed: 34109765
Clin Microbiol Infect. 2021 Jul;27(7):1041.e1-1041.e4
pubmed: 34125067
PLoS One. 2019 Feb 4;14(2):e0211532
pubmed: 30716129
BMC Med. 2021 May 20;19(1):129
pubmed: 34011359
Clin Infect Dis. 2021 Jul 05;:
pubmed: 34223884
Clin Microbiol Infect. 2021 Jan;27(1):89-95
pubmed: 32979574
JAMA Netw Open. 2021 Feb 1;4(2):e210830
pubmed: 33606031
Lancet. 2020 Dec 12;396(10266):1861
pubmed: 33308453

Auteurs

Agnese Comelli (A)

Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Giulia Viero (G)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Greta Bettini (G)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Alessandro Nobili (A)

Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Mauro Tettamanti (M)

Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Alessia Antonella Galbussera (AA)

Department of Health Policy, Istituto di Ricerche Farmacologiche Mario Negri Istituti di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Antonio Muscatello (A)

Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Marco Mantero (M)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Cystic Fibrosis Adult Centre, Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Ciro Canetta (C)

Acute Medical Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Filippo Martinelli Boneschi (F)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Neurology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Neurosciences and Mental Health, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Andrea Arighi (A)

Neurology Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paolo Brambilla (P)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Department of Neurosciences and Mental Health, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Maurizio Vecchi (M)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Gastroenterology and Endoscopy Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Pietro Lampertico (P)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
CRC "A. M. and A. Migliavacca" Center for Liver Disease, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paolo Bonfanti (P)

Infectious Diseases Unit, Azienda Socio Sanitaria Territoriale Monza, San Gerardo Hospital, Monza, Italy.

Marco Contoli (M)

Research Centre on Asthma and Chronic Obstructive Pulmonary Disease, Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Francesco Blasi (F)

Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.
Respiratory Unit and Cystic Fibrosis Adult Centre, Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Andrea Gori (A)

Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Alessandra Bandera (A)

Infectious Diseases Unit, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

Classifications MeSH